23 March 2022
In the Netherlands over 2.5 million patients suffer from chronic inflammatory skin diseases. Although not life-threatening, the personal impact and socio-economic costs of these chronic conditions are very high. The biggest problem is that many treatments are not suited for every patient and often do not work.
NGID will tackle this problem and will develop the right care for the right patient at the right time. Within this 6-year project six inflammatory skin diseases will be investigated in ultra-high detail. For this approach, a unique, international consortium consisting of scientific institutes, universities, high-tech companies, hospitals, patient associations and (bio)pharmaceutical industry has been setup. Dermatologists from all Dutch University Medical Centers will be connected to biologists, bio-informaticians, statisticians, behavioural scientists, communication researchers and of course to the patient. By means of a new data analysis and integration approach, NGID will make patient-specific fingerprints that will guide the best care for the individual patient in the future.
Age Smilde of the Swammerdam Institute for Life Sciences from the UvA (SILS-UvA) is involved in the consortium. He will use his expertise on data analysis to focus on integrating all data in the project to distil non-invasive biomarkers.
The funding round for Research along Routes by Consortia (NWA-ORC) is annually awarded. All projects fit the Dutch Research Agenda. This year 28 consortia are awarded. More information can be found here on the NWO website.